Brazil vs Tanzania: The number of people with susceptibility test result for rifampicin
Brazil
24,394
in 2021
Tanzania
26,624
in 2021
Brazil rank
14th
Tanzania rank
12th
The number of people with susceptibility test result for rifampicin over time
- Brazil
- Tanzania
How they compare
Tanzania currently reports 26,624 against 24,394 in Brazil, a difference of 2,230.
That makes Tanzania's figure about 1.1 times Brazil's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Brazil ahead.
Brazil ranks 14th and Tanzania ranks 12th of 155 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20,251 | 16,817 | 3,434 | Brazil |
| 2020s | 24,076 | 22,648 | 1,428 | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brazil or Tanzania?
- Tanzania, at 26,624 against 24,394 in Brazil as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brazil and Tanzania?
- 2,230, with Tanzania ahead.
- How many years of comparable data are there for Brazil and Tanzania?
- 5 years are reported by both, from 2017 to 2021.
- How do Brazil and Tanzania rank globally for the number of people with susceptibility test result for rifampicin?
- Brazil ranks 14th and Tanzania ranks 12th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.